Parexel is a global clinical research organization (CRO) that provides end-to-end clinical development solutions for pharmaceutical and biotechnology companies. Its services span the entire drug development lifecycle, including Phase I to IV clinical trials, regulatory consulting, data management, statistical programming, medical safety, and market access strategy. The company also works in innovative trial designs and advanced technology to accelerate the development of new therapies.
With over 24,000 professionals operating across 84+ facilities in 49 countries, Parexel maintains a substantial global footprint. The organization serves clients in the pharmaceutical, biotechnology, and broader healthcare sectors, supporting them through comprehensive clinical research and development programmes.
Parexel describes its culture as built on collaboration, expertise, and a commitment to quality and patient safety. The company emphasises an approach characterised by deep conviction and empathy for patients, and positions itself as a place where professionals can grow their careers while contributing to global healthcare outcomes.
